DOI: https://doi.org/10.14710/jai.v8i3.19817

Manajemen Transfusi Perioperatif Pada Pasien Bedah Jantung Dewasa dengan Mesin Pintas Jantung Paru

Departemen Anestesi dan Perawatan Intensif Pasca Bedah RS Pusat Jantung Nasional Harapan Kita, Jakarta, Indonesia

Published: 1 Nov 2016.
Open Access Copyright 2016 (JAI) Jurnal Anestesiologi Indonesia

Citation Format:
Abstract

Transfusi darah umum dilakukan pada pasien bedah jantung, mencakup 10-20% dari total transfusi darah yang diberikan. Diperkirakan 60-70% pemberian transfusi terjadi selama periode perioperatif. Pemintasan jantung paru menggunakan mesin pintas jantung paru/ cardiopulmonary bypass (CPB) machine merupakan teknik penting yang telah digunakan selama lebih dari 60 tahun. Mesin ini membantu dokter bedah jantung mendapatkan area kerja yang tidak bergerak dan bersih. Dalam konteks koagulasi, pemakaian mesin CPB akan mengakibatkan timbulnya anemia hemodilusi akibat priming, sehingga seringkali memerlukan transfusi darah.Beberapa penelitian menunjukkan keterkaitan antara transfusi alogenik terkait dengan peningkatan morbiditas seperti infeksi, cidera ginjal akut, reaksi hemolitik akut, reaksi alergi, cidera paru, kelebihan cairan, dan peningkatan mortalitas.Pemberian transfusi alogenik dapat dikurangi dengan protokol transfusi restriktif, penggunaan metode autotransfusi, pemberian eritropoetin (EPO), antiplatelet, dan antifibrinolitik. Manajemen transfusi yang tepat dan rasional selama periode perioperatif bedah jantung dapat menurunkan mortalitas dan morbiditas secara signifikan.

 

Fulltext View|Download
Keywords: anemia hemodilusi; autotransfusi; mesin pintas jantung paru

Article Metrics:

Article Info
Section: Literature Reviews
Language : ID
Recent articles
Pengaruh Pemberian Minuman Karbohidrat Preoperasi Terhadap Kadar Glukosa Darah dan Tingkat Kecemasan Pasien yang Akan Menjalani Operasi Pengaruh Dexmedetomidine Intravena Terhadap Kadar Superoxide Dismutase 1 (SOD-1) Ginjal Kelinci Padarenal Ischemic Reperfusion Injury Model Validitas Skor Apache II, MSofa, dan SAPS 3 Terhadap Mortalitas Pasien Non Bedah di Perawatan Intensif Dewasa RSUP dr Kariadi Semarang Extracorporeal Membrane Oxygention (ECMO) Pada Pasien Bedah Jantung Dewasa Perioperatif Early Goal Directed Theraphy Pada Bedah Jantung Manajemen Transfusi Perioperatif Pada Pasien Bedah Jantung Dewasa dengan Mesin Pintas Jantung Paru More recent articles
Most cited articles
Midazolam Intravena Dosis Rendah Tidak Mempengaruhi Nitric Oxide Intraperitoneal Mencit Balb/C Yang Terpapar Lipopolisakarida Patofisiologi Penyakit Jantung Koroner More cited articles
  1. Steidl S. The adverse effect of the cardiopulmonary bypass machine [Senior's thesis]. Lynchburg (VA): Liberty University; 2011.35p
  2. D. Gavish, T. Ezri, A. Klepfish, A. A. Weinbroum, A. Izakso,n S. Evron. Perioperative blood transfusion: a brief review ofpros and cons .J Rom Anest Terap Int 2010; 17: 134-139
  3. Bilgin YM, Watering LMG. Complications after cardiac surgery due to allogeneic blood transfusions. J Clin Exp Cardiolog 2013; S7: 005
  4. Galas FRBG, ALmeida JP, Fukushima JT, Osawa EA, Nakamura RE, Silva CMPDC, et al. Blood ransfusion in cardiac surgery is a risk factor for increased hospital length of stay in adult patients.J Cardiothorac Surg 2013;8:54
  5. Simon TL, Alverson DC, AuBuchon J, Cooper ES, DeChristopher PJ, Glenn GC et al. Practice parameter for the use of red blood cell transfusions: developed by the Red Blood Cell Administration Practice Guideline Development Task Force of the College American Pathologists. Arch Pathol Lab Med 1998; 122:130-8
  6. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologist Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2015; 122:241-75
  7. Esper SA, Subramaniam K, Tanaka KA. Pathophysiology of cardiopulmonary bypass: current strategies for the prevention and treatment of anemia, coagulopathy, and organ dysfunction.Semin Cardiothorac Vasc Anesth 2014;18:161-76
  8. Levy JH. Kessler CM (editor) The effects of cardiopulmonary bypass on coagulation. Clin Adv Hematol Oncol 2013;11:589-91
  9. Wilkinson KL, Brunskill SJ, Doree C, Trivella M, Gill R, Murphy MF.Red cell transfusion management for patients undergoing cardiac surgery for congenital heart disease.Cochrane Database Syst Rev 2014;2:CD009752
  10. Liumbruno GM, Bennardello F, Lattanzio A, Piccoli P, Rossetti G. Recommendations for the transfusion management of patients in the peri-operative period. I. The pre-operative period. Blood Transfus. 2011; 9: 19–40
  11. Ferraris et al. 2011 Update of The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines. The Annals of Thoracic Surgery 2011;91:944-82
  12. Farland JG. Perioperative blood transfusions: indications and options. Chest 1999; 115: (suppl)113S–21S
  13. Mangu HR, Samantaray A, Anakapalli M. Blood transfusion practices in cardiac anaesthesia. Indian J Anaesth 2014;58:616-21
  14. Sharma S, Sharma P, Tyler LN. Transfusion of blood and blood products: indication and complication. Am Fam Physician 2011;83(6):719-24
  15. Rohde JM, Dimcheff DE, Blumberg N, Saint S, Langa KM, Kuhn L, et al. Health care-associated infection after red blood cell transfusion: A systematic review and meta-analysis.JAMA 2014;311:1317-26
  16. Karkouti K. Transfusion and Risk of Acute Kidney Injury in Cardiac Surgery. Br J Anaesth 2012;109 (Suppl 1):i29-i38
  17. Tjutanto R, Wuwungan AA, Lalenoh HJ. Autotransfusi perioperatif. Jurnal Biomedik 2013;5:17-20
  18. Ashworth A, Klein AA. Cell salvage as part of a blood conservation strategy in anaesthesia.Br J Anaesth 2010;105:401-16
  19. Engels GE, van Klarenbosch J, Gu YJ, van Oeveren W, de Vries AJ. Intraoperative Cell Salvage during Cardiac Surgery is Assoiated with Reduced Postoperative Lung Injury. Interact Cardiovasc Thorac Surg. 2016;22:298-304
  20. Liumbruno GM, Bennardello F, Lattanzio A, Piccoli P, Rossetti G. Recommendations for the transfusion management of patients in the peri-operative period. III. The post-operative period.Blood Transfus. 2011;9:320-35
  21. Weltert L, Rondinelli B, Bello R, Falco M, Bellisario A, Maselli D, et al. A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: results of a prospective single – blind randomized controlled trial. Transfusion 2015;55:1644-54
  22. Cladellas M, Farré N, Comín-Colet J, Gómez M, Meroño O, Bosch MA, et al. Effects of preoperative intravenous erythropoietin plus iron on outcome in anemic patients after cardiac valve replacement. Am J Cardiol 2012;110:1021-6
  23. Haydar AA, Abchee AB, El-Hajj II, Hujairi NMA, Tfaili AS,Hatoum T, et al. Bleeding post coronary artery bypass surgery, clopidogrel – cure of culprit? Leb Med J 2006; 54: 11-16
  24. Maltais S, Perrault LP, Do QB. Effect of clopidogrel on bleeding and transfusions after off-pump coronary artery bypass graft surgery: impact of discontinuation prior to surgery. Eur J Cardiothorac Surg 2008;34:127-31
  25. Liumbruno GM, Bennardello F, Lattanzio A, Piccoli P, Rossetti G. Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period. Blood Transfus 2011;9:189–217

Last update:

No citation recorded.

Last update: 2024-12-26 05:59:06

No citation recorded.